Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Winston Biotech Co LtdfiledCriticalWinston Biotech Co Ltd
Priority to TW095109221ApriorityCriticalpatent/TWI367254B/en
Publication of TW200736394ApublicationCriticalpatent/TW200736394A/en
Application grantedgrantedCritical
Publication of TWI367254BpublicationCriticalpatent/TWI367254B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention relates to a method of inhibiting the tyrosinase translation, which includes inhibiting the translation of fragment coating from the first sequence region TIF-1 of tyrosinase or from the secondary sequence region TIF-2 of tyrosinase. This invention also relates to the method of inhibiting the melanin production, and the nucleic acids and the pharmaceutical composition of inhibiting tyrosinase translation or melanin production.
TW095109221A2006-03-172006-03-17Method, nucleic acid and pharmaceutical composition for inhibiting tyrosinase translation
TWI367254B
(en)
To novel compounds which are effective as an inhibitor for xanthine oxidase, a process for preparing the same, and a pharmaceutical composition comprising a therapeutically effective amount of the same